Dr Reddys Laboratories (RDY) Payables (2012 - 2026)

Dr Reddys Laboratories' Payables history runs 15 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• In Q1 2026, Payables rose 19.16% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (up 19.16% YoY), while the FY2026 annual figure was $986.0 million, up 14.39% from the prior year.
• Payables was $1.0 billion for Q1 2026 at Dr Reddys Laboratories, up from $573.2 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.0 billion in Q1 2026 to a low of $29.7 million in Q2 2024.
• Historically, Payables has averaged $445.6 million across 5 years, with a median of $470.6 million in 2023.
• Biggest YoY gain for Payables was 317.32% in 2024; the steepest drop was 92.85% in 2024.
• A 5-year view of Payables shows it stood at $105.5 million in 2022, then rose by 19.38% to $126.0 million in 2023, then surged by 317.32% to $525.8 million in 2024, then increased by 9.03% to $573.2 million in 2025, then surged by 76.6% to $1.0 billion in 2026.
• The last three Payables figures came in at $1.0 billion (Q1 2026), $573.2 million (Q3 2025), and $72.5 million (Q2 2025), per Business Quant data.